about
Prevalence of microalbuminuria in non-diabetic hypertensive patients attended by Portuguese GPsPERSYVE - Design and validation of a questionnaire about adverse effects of antihypertensive drugs.Paraganglioma--a case of secondary hypertension.Annual deterioration of renal function in hypertensive patients with and without diabetes.2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).Diagnostic value and cost-benefit analysis of 24 hours ambulatory blood pressure monitoring in primary care in PortugalFactors that influence spontaneous reporting of adverse drug reactions: a model centralized in the medical professional.Reliable Quantification of the Potential for Equations Based on Spot Urine Samples to Estimate Population Salt Intake: Protocol for a Systematic Review and Meta-Analysis.Drug-induced anaphylaxis: a decade review of reporting to the Portuguese Pharmacovigilance Authority.Prognostic impact from clinic, daytime, and night-time systolic blood pressure in nine cohorts of 13,844 patients with hypertension.Prognostic impact of sex-ambulatory blood pressure interactions in 10 cohorts of 17 312 patients diagnosed with hypertension: systematic review and meta-analysis.Relationship between ambulatory blood pressure monitoring values and future occurrence of ischemic cerebrovascular and coronary events in hypertensive patients.[Reduction of the antihypertensive effects of enalapril by indomethacin. Its independence from renal sodium retention]Different patterns of peripheral versus central blood pressure in hypertensive patients treated with β-blockers either with or without vasodilator properties or with angiotensin receptor blockers.Possible phototoxicity with subsequent progression to discoid lupus following pantoprazole administration.A survey of spontaneous reporting of adverse drug reactions in 10 years of activity in a pharmacovigilance centre in Portugal.Global cardiovascular risk stratification of hypertensive patients followed in Portugal in primary care or in hospital care according to the 2007 ESH/ESC guidelines.Prevalence, awareness, treatment and control of hypertension and salt intake in Portugal: changes over a decade. The PHYSA study.Prognostic significance of ambulatory arterial stiffness index in hypertensives followed for 8.2 years: its relation with new events and cardiovascular risk estimation.Aortic pulse wave velocity and HeartSCORE: improving cardiovascular risk stratification. a sub-analysis of the EDIVA (Estudo de DIstensibilidade VAscular) project.Improving the reporting of adverse drug reactions: a cluster-randomized trial among pharmacists in Portugal.Estimation of salt intake by urinary sodium excretion in a Portuguese adult population and its relationship to arterial stiffness.Efficacy of captopril and nifedipine in black and white patients with hypertensive crisis.Influence of salt intake on the daytime-nighttime blood pressure variation in normotensive and hypertensive black subjects.ISVH Society September Newsletter.Cardiovascular prognostic value of ambulatory blood pressure monitoring in a Portuguese hypertensive population followed up for 8.2 years.The complex relationship between nocturnal obstructive apnea and high blood pressure. The eternal question of the chicken and the egg.Sequential follow-up clinic and ambulatory blood pressure evaluation in a low risk population of white-coat hypertensive patients and in normotensives.Salt intake in children 10-12 years old and its modification by active working practices in a school garden.6A.05: THE PROGNOSTIC VALUE OF AMBULATORY ARTERIAL STIFFNESS INDEX AS A PREDICTOR OF CARDIOVASCULAR EVENTS IN RESISTANT HYPERTENSIVE PATIENTS?1B.05: IN HYPERTENSION THE CHANGE FROM A NON-DIPPER TO A DIPPER PATTERN IS ASSOCIATED WITH A BETTER CARDIOVASCULAR PROGNOSIS THAN THE PERSISTENCE WITHIN THE NON-DIPPER PATTERN.Arterial stiffness predicts cardiovascular outcome in a low-to-moderate cardiovascular risk population: the EDIVA (Estudo de DIstensibilidade VAscular) project.[A statistical definition of aortic pulse wave velocity normality in a Portuguese population: a subanalysis of the EDIVA project].Different patterns of one-year evolution of microalbuminuria in hypertensive patients treated with different inhibitors of the renin-angiotensin system.Prognostic value of subdivisions of nighttime blood pressure fall in hypertensives followed up for 8.2 years. Does nondipping classification need to be redefined?Relationship of circadian blood pressure and morning blood pressure surge with the severity of metabolic syndrome in newly diagnosed hypertensives.Blood pressure on arising, morning blood pressure surge and blood pressure variability in white coat hypertensives and in matched normotensives and sustained hypertensives.Pharmacological characterization of postsynaptic alpha-adrenoceptor subtypes in five different dog arteries in-vitro.Nurses' attitudes and spontaneous adverse drug reaction reporting: a case-control study in Portugal.Workshop- and telephone-based interventions to improve adverse drug reaction reporting: a cluster-randomized trial in Portugal.
P50
Q28221387-A20CE005-2228-4287-A0A5-4B44B49051FAQ30583850-71C42B2B-E62F-487B-87F8-79B3CB079B73Q33159648-4F76EB98-AE5A-47D4-B563-98188DFDA451Q33875371-94D1CB21-1AD7-404B-ABF0-89A5D173BDBBQ34351265-54344737-3991-4DAC-A50D-1921A48E4161Q34927938-FBBEC2EF-A349-453C-A338-7F0078555C72Q35917635-4AB47DE4-4973-4D2A-BD56-A43CB7D9676CQ36140055-0489D64D-F64B-4202-9672-F2E337D5F9CFQ38036926-A62B4F41-198C-40B8-88BF-9EAF286F535AQ38261728-B4B7497B-AC11-42C4-BD1E-473A1831C5F1Q38283744-EFFA27A0-2731-4E6C-8A91-C03FD74FB48CQ40313970-3C6A1883-92D1-4310-B9D5-B83C88123E0DQ42554734-D42014F0-C736-4547-BE36-659D90F4BF54Q43006065-2AB2DBFD-4F0B-4417-82B6-ABD31ED269E2Q43697991-380B92AE-5194-492E-8A63-D93F25E7BDA4Q43763549-9829FA45-0611-451F-8E58-B2C5E4FB788DQ43818869-5EE41513-5D84-48F7-827F-34CFABACDD3DQ44084049-8BB6B90A-5DAD-49C4-8ED7-7A3BC85DC6E6Q44666359-9CC818CA-341F-4B8A-8DD2-341EF98C42ACQ45533771-39CBB873-F091-4475-ADAB-8ED443D51E2CQ45740000-65E84109-5A92-44DB-B0CF-9DF1E7DEABE1Q46331279-D937C7B5-768A-4783-A7AB-7F91331FC4CBQ46493229-3FE2454E-B3D6-45AA-93EE-05A6E5201C87Q46519290-68E1B46E-5E38-4D96-8B32-778277816A5BQ47110853-945A7870-93BB-41E5-836D-C871A76C38C5Q48350280-074BCFFF-D180-4013-886E-DE6B2FF19556Q48707776-B82E04DD-8DC1-491D-8986-6C62741E164DQ50759401-C358F728-B22B-4FC7-9E9C-D77B138E4E01Q50765695-31ABB88B-8924-4EF7-A500-14654B47D4F3Q51013104-3E5CA24F-11E6-446D-8707-2D6240D24FA3Q51013403-11468148-EC3A-45DA-A39F-F3383C88C89EQ51157587-5B308875-01E0-4187-8D0A-C2F776A99AFFQ51170610-C1768EFE-3923-4850-8D54-7B70B877ABB0Q51655667-ED71BD69-53AC-447A-BC53-AF44CCC7D590Q51679898-399A6900-4C7D-40E0-A697-1FC1AD4F4CFEQ51732505-A281293B-D05D-431C-B66D-7A7CFE961EF4Q51778720-A726D17E-3AFB-4614-AB75-8DCCD1691D67Q51830541-AB511C12-6864-4D6E-A22B-9DE01BB6F645Q52800450-C69700C8-0E24-4ACE-B985-A741B79832E2Q52802544-66A95527-E29A-4FA8-89DE-932C0B03B6FB
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Jorge J Polónia
@nl
Jorge J Polónia
@sl
Jorge J. Polónia
@en
Jorge J. Polónia
@es
type
label
Jorge J Polónia
@nl
Jorge J Polónia
@sl
Jorge J. Polónia
@en
Jorge J. Polónia
@es
prefLabel
Jorge J Polónia
@nl
Jorge J Polónia
@sl
Jorge J. Polónia
@en
Jorge J. Polónia
@es
P106
P1153
8074290400
P21
P31
P496
0000-0002-0133-7217